Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock – A European experienced users working group opinion
التفاصيل البيبلوغرافية
العنوان:
Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock – A European experienced users working group opinion
Schafer, A., Werner, N., Westenfeld, R., Moller, J. E., Schulze, P. C., Karatolios, K., Pappalardo, F., Maly, J., Staudacher, D., Lebreton, G., Delmas, C., Hunziker, P., Fritzenwanger, M., Napp, L. C., Ferrari, M., Tarantini, G.
المصدر:
Schäfer, A, Werner, N, Westenfeld, R, Møller, J E, Schulze, P C, Karatolios, K, Pappalardo, F, Maly, J, Staudacher, D, Lebreton, G, Delmas, C, Hunziker, P, Fritzenwanger, M, Napp, L C, Ferrari, M & Tarantini, G 2019, ' Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock – A European experienced users working group opinion ', International Journal of Cardiology, vol. 291, pp. 96-104 . https://doi.org/10.1016/j.ijcard.2019.05.044Test
For patients with myocardial infarct-related cardiogenic shock (CS), urgent percutaneous coronary intervention is the recommended treatment strategy to limit cardiac and systemic ischemia. However, a specific therapeutic intervention is often missing in non-ischemic CS cases. Though drug treatment with inotropes and/or vasopressors may be required to stabilize the patient initially, their ongoing use is associated with excess mortality. Coronary intervention in unstable patients often leads to further hemodynamic compromise either during or shortly after revascularization. Support devices like the intra-aortic balloon pump failed to improve clinical outcomes in infarct-related CS. Currently, more powerful and active hemodynamic support devices unloading the left ventricle such as transvalvular microaxial pumps are available and are being increasingly used. However, as for other devices large randomized trials are not yet available, and device use is based on registry data and expert consensus. In this article, a multidisciplinary group of experienced users of transvalvular microaxial pumps outlines the pathophysiological background on hemodynamic changes in CS, the available mechanical support devices, and current guideline recommendations. Furthermore, different hemodynamic situations in several case-based scenarios are used to illustrate candidate settings and to provide the theoretic and scientific rationale for left-ventricular unloading in these scenarios. Finally, organization of shock networks, monitoring, weaning, and typical complications and their prevention are discussed.
